ASCO 2021 Annual Meeting Jun 4 - Jun 8, 2021 Supporting Materials Phase 1 Dose Escalation Study of MGC018, an anti-B7-H3 ADC In Patients with Advanced Solid Tumors 549.4 KB
Phase 1 Dose Escalation Study of MGC018, an anti-B7-H3 ADC In Patients with Advanced Solid Tumors 549.4 KB